non-cardioembolic
Showing 1 - 25 of >10,000
Ischemic Stroke Trial (Renexin CR 200/160mg, Plavix 75mg)
Recruiting
- Ischemic Stroke
- Renexin CR 200/160mg
- Plavix 75mg
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 2, 2023
Ischemic Stroke, Transient Ischemic Attack Trial in Sari (Ticagrelor 90mg, Clopidogrel 75 mg)
Recruiting
- Ischemic Stroke
- Transient Ischemic Attack
- Ticagrelor 90mg
- Clopidogrel 75 mg
-
Sari, Mazandaran, Iran, Islamic Republic of
- +1 more
Aug 29, 2021
Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))
Recruiting
- Prevention of Thromboembolic Events
- +4 more
- Asundexian (BAY2433334)
-
Kiel, Schleswig-Holstein, GermanyCRS-Kiel
Jan 17, 2023
Ischemic Stroke Trial in Baoji, Xi'an, Xianyang (low-dose aspirin, conventional-does aspirin)
Recruiting
- Ischemic Stroke
- low-dose aspirin
- conventional-does aspirin
-
Baoji, Shaanxi, China
- +5 more
Feb 7, 2022
Acute Non-cardioembolic Ischemic Stroke Trial in Worldwide (BAY2433334, BAY2433334 matching )
Completed
- Acute Non-cardioembolic Ischemic Stroke
- BAY2433334
- BAY2433334 matching placebo
-
Tampa, Florida
- +196 more
Jun 29, 2022
Cardioembolic Stroke, Multidisciplinary Communication Trial in Nanchang (Multidisciplinary joint diagnosis and treatment mode)
Active, not recruiting
- Cardioembolic Stroke
- Multidisciplinary Communication
- Multidisciplinary joint diagnosis and treatment mode
-
Nanchang, Jiangxi, ChinaThe Second Affiliated Hospital of Nanchang University
Aug 10, 2022
Keeping Oral o Parental AnticoaguLation in Acute Phase of
Recruiting
- Cardioembolic Stroke
- +3 more
- Observation
-
Paris, France
- +2 more
Aug 2, 2022
Prevention of Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, High-risk Transient Ischemic Attack Trial in Worldwide
Not yet recruiting
- Prevention of Ischemic Stroke
- +2 more
- Asundexian (BAY2433334)
- Placebo
-
Fairhope, Alabama
- +716 more
Jan 16, 2023
Biomarkers of Acute Stroke in Clinic
Recruiting
- Ischemic Stroke
- +16 more
- ISCDX blood test
-
Columbus, OhioOhio Health Riveside Methodist Hospital
Aug 23, 2021
Atrial Fibrillation, Anticoagulants and Bleeding Disorders Trial in Netherlands (Left atrial appendage occlusion (Watchman FLX
Recruiting
- Atrial Fibrillation
- Anticoagulants and Bleeding Disorders
- Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet)
-
Leeuwarden, Friesland, Netherlands
- +13 more
Dec 19, 2022
Atrial Fibrillation Trial in Prague (NOAC, Left atrial appendage closure)
Completed
- Atrial Fibrillation
- NOAC
- Left atrial appendage closure
-
Prague, CzechiaCardiocenter, 3rd Medical School, Charles University and Univers
Jun 9, 2021
Stroke Trial in Paris (Cardiac scanner)
Recruiting
- Stroke
- Cardiac scanner
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jan 18, 2022
Ischemic Stroke Trial in Saint-Étienne (Blood collection before antiplatelet treatment, Blood collection after antiplatelet
Not yet recruiting
- Ischemic Stroke
- Blood collection before antiplatelet treatment
- Blood collection after antiplatelet treatment
-
Saint-Étienne, FranceCentre Hospitalier Universitaire de St-Etienne
Jan 13, 2023
Thromboembolism in the Pathogenesis of Ischaemic Stroke
Not yet recruiting
- Stroke
- +2 more
- 18F-GP1 PET/CT
- +3 more
- (no location specified)
Dec 6, 2022
Ischemic Stroke, Atrial Fibrillation, Hemorrhagic Transformation Stroke Trial in Edmonton (Edoxaban 60 MG, Edoxaban 30 mg)
Recruiting
- Ischemic Stroke
- +2 more
- Edoxaban 60 MG
- Edoxaban 30 mg
-
Edmonton, Alberta, CanadaUniversity of Alberta
Apr 6, 2022
Validation of 3D Simulations in Embolic Stroke
Active, not recruiting
- Stroke
- Stroke simulation and machine learning
-
Leicester, Leicestershire, United KingdomUniversity of Leicester
Feb 25, 2022
Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)
Completed
- Ischemic Stroke
- +6 more
- Biomarker blood draw
-
Sacramento, California
- +21 more
Jul 7, 2020
Atrial Fibrillation, Antithrombotic Therapy, Acute Coronary Syndrome Trial in Gdansk (Ticagrelor, Dabigatran Etexilate, Aspirin)
Recruiting
- Atrial Fibrillation
- +3 more
- Ticagrelor
- +3 more
-
Gdańsk, Pomorskie, PolandCardiac lntensive Care Unit, First Department of Cardiology, Uni
Oct 27, 2021
Left Ventricular Thrombus, Myocardial Infarction Trial (Rivaroxaban, Warfarin)
Not yet recruiting
- Left Ventricular Thrombus
- Myocardial Infarction
- (no location specified)
Mar 31, 2023
Left Atrial Appendage Closure Trial in Worldwide (Amplatzer Amulet for left atrial appendage closure, Watchman/FLX for left
Active, not recruiting
- Left Atrial Appendage Closure
- Amplatzer Amulet for left atrial appendage closure
- Watchman/FLX for left atrial appendage closure
-
Charleroi, Belgium
- +7 more
Mar 14, 2022
Atrial Cardiomyopathy in Stroke of Undetected Mechanism
Active, not recruiting
- Stroke
-
Copenhagen NV, Copenhagen, DenmarkBispebjerg Hospital
Apr 4, 2022
Acute Ischemic Stroke, Haemorrhagic Stroke, Transient Ischemic Attacks Trial in Hong Kong (Biomarker blood draw and saliva
Recruiting
- Acute Ischemic Stroke
- +11 more
- Biomarker blood draw and saliva collection
-
Hong Kong, ChinaHong Kong University
Jul 3, 2022
sCLEC-2 in Stroke Study
Not yet recruiting
- Acute Ischemic Stroke
- Transient Ischemic Attack
-
Katori, Chiba, Japan
- +8 more
Oct 10, 2022
Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual
Recruiting
- Atrial Fibrillation
- short postimplantation dual antiplatelet therapy
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute of Cardiology
Dec 14, 2022
Intraventricular Stasis In Cardiovascular Disease
Recruiting
- Dilated Cardiomyopathy
- +3 more
- Doppler echocardiogram exam
- +4 more
-
Barcelona, Spain
- +2 more
Feb 3, 2022